Methods for implementing a medicine outlet survey: Lessons from the anti-malarial market

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  O'Connell, Kathryn A ^a   Poyer, Stephen ^a   Solomon, Tsione ^a   Munroe, Erik ^a   Patouillard, Edith ^b   Njogu, Julius ^a   Evance, Illah ^a   Hanson, Kara ^b   Shewchuk, Tanya ^a   Goodman, Catherine ^b  

^a POPULATION SERVICES INTERNATIONAL   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

availability; Health facility survey; Market share; Medicine; Price; Private sector; Retail outlet survey methods

Indexed keywords

ANTIMALARIAL AGENT;

DATA ANALYSIS; DEVELOPING COUNTRY; DRUG BIOAVAILABILITY; DRUG COST; DRUG MARKETING; HEALTH CARE PLANNING; HEALTH SURVEY; OUTLET SURVEY; PRACTICE GUIDELINE; QUALITY CONTROL; QUESTIONNAIRE; REVIEW; STUDY DESIGN;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ASIA; DEVELOPING COUNTRIES; DRUG UTILIZATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA;

EID: 84873266301     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-52     Document Type: Review

References (33)

1. World Health Organization, The World Medicines Situation Geneva: World Health Organization 2004
2. United Nations Development Group, Indicators for Monitoring the Millennium Development Goals New York: United Nations Development Group 2003
3. Universal access to malaria medicines: innovation in financing and delivery. Adeyi O, Atun R, Lancet 2010 376 1869 1871 10.1016/S0140-6736(10) 61189-0 20940074
4. WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance. Cui W, BMJ 2011 4 342
5. Iddy Mayumana I, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions-a user perspective. Alba S, Dillip A, Hetzel MW, Malar J 2010 9 163 10.1186/1475-2875-9-163 20550653
6. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Yeung S, Patouillard E, Allen H, Socheat D, Malar J 2011 10 243 10.1186/1475-2875-10-243 21851625
7. 10 best resources for measuring population health. David P, Haberlen S, Health Policy Plan 2005 20 260 263 10.1093/heapol/czi030 15965038 (Pubitemid 40942569)
8. Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review. Conteh L, Hanson K, Soc Sci Med 2003 57 1147 1161 10.1016/S0277-9536(02)00491-4 12899900 (Pubitemid 36945242)
9. Poor quality vital anti-malarials in Africa-an urgent neglected public health priority. Newton PN, Green MD, Mildenhall DC, Plançon A, Nettey H, Nyadong L, Hostetler DM, Swamidoss I, Harris GA, Powell K, Timmermans AE, Amin AA, Opuni SK, Barbereau S, Faurant C, Soong RC, Faure K, Thevanayagam J, Fernandes P, Kaur H, Angus B, Stepniewska K, Guerin PJ, Fernández FM, Malar J 2011 10 352 10.1186/1475-2875-10-352 22152094
10. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. OConnell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D, Malar J 2011 10 326 10.1186/1475-2875-10-326 22039838
11. The ACTwatch project: methods to describe anti-malarial markets in seven countries. Shewchuk T, OConnell KA, Goodman C, Hanson K, Chapman S, Chavasse D, Malar J 2011 10 325 10.1186/1475-2875-10-325 22039780
12. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Kachur SP, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland PB, Trop Med Int Health 2006 11 441 451 10.1111/j.1365-3156.2006.01588.x 16553927
13. A public-health approach to site-specific formulary management: addressing deficient drug supplies in Malawi. Lauffenburger JC, Jonkman LJ, Lange CE, Connor SE, Sibale C, Int J Pharm Pract 2011 19 201 205 10.1111/j.2042-7174.2011.00114.x 21554446
14. The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya. Sudoi RK, Githinji S, Nyandigisi A, Muturi A, Snow RW, Zurovac D, Malar J 2012 11 37 10.1186/1475-2875-11-37 22316236
15. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P, Trop Med Int Health 2004 9 655 663 10.1111/j.1365-3156. 2004.01245.x 15189455 (Pubitemid 38833330)
16. Decreased availability of anti-malarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley. Hetzel MW, Msechu JJ, Goodman C, Lengeler C, Obrist B, Kachur SP, Makemba A, Nathan R, Schulze A, Mshinda H, Tanzania. Malar J 2006 5 109
17. Medicines for Malaria Venture, Understanding the Anti-malarials Market Geneva: Medicines for Malaria Venture: Uganda 2007-an overview of the supply side 2008
18. Availability and choice of anti-malarials at medicine outlets in Ghana: the question of access to effective medicines for malaria control. Buabeng KO, Duwiejua M, Matowe LK, Smith F, Enlund H, Clin Pharmacol Ther 2008 84 613 619 10.1038/clpt.2008.130 18615006
19. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R, Lancet 2009 373 240 249 10.1016/S0140-6736(08)61762-6 19042012
20. Brands, costs and registration status of anti-malarial drugs in the Kenyan retail sector. Amin AA, Snow RW, Malar J 2005 4 36 10.1186/1475-2875-4-36 16042815 (Pubitemid 41192060)
21. Expiry of medicines in supply outlets in Uganda. Nakyanzi JK, Kitutu FE, Oria H, Kamba PF, Bull World Health Organ 2010 88 154 158 10.2471/BLT.08.057471 20428373
22. Increasing access to subsidized artemisinin-based combination therapy through accredited drug dispensing outlets in Tanzania. Rutta E, Kibassa B, McKinnon B, Liana J, Mbwasi R, Mlaki W, Embrey M, Gabra M, Shekalaghe E, Kimatta S, Sillo H, Health Res Policy Syst 2011 9 22 10.1186/1478-4505-9-22 21658259
23. Patouillard E, An economic analysis of the market for malaria treatment in Cambodia. PhD Thesis University of London, London School of Hygiene and Tropical Medicine: Department of Public Health and Policy 2012
24. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C, PLoS One 2009 4 6857 10.1371/journal.pone.0006857 19724644
25. World Health Organization Collaborating Centre for Drug Statistics Methodology, Complete ATC Index Norwegian Institute of Public Health 2005
26. Goodman CA, An economic analysis of the retail market for fever and malaria treatment in rural Tanzania Department of Public Health and Policy: PhD Thesis. University of London, London School of Hygiene and Tropical Medicine 2004
27. Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A, Health Econ 2009 18 727 742 10.1002/hec.1473 19301420
28. ACTwatch, website: www.actwatch.info
29. World Health Organization and Health Action International, Medicine Prices: A New Approach to Measurement Geneva: World Health Organization and Health Action International 2003
30. World Health Organization and Health Action International, Measuring Medicine Prices, Availability, Affordability and Price Components Geneva: World Health Organization and Health Action International 2008
31. Beitz J, Romero V, Prices of Reproductive Health Medicines in Nicaragua Seattle: PATH 2006
32. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M, Bull World Health Organ 2007 85 279 288 10.2471/BLT.06.033647 17546309 (Pubitemid 46556727)
33. Rao R, Thapa D, Nepal: Reproductive Health Commodity Pricing Survey Arlington: John Snow: Understanding Equity, Access, and Affordability of Essential Reproductive Health Commodities 2005